Summary

Dr. Reed Berger, MD, PNS, an obesity medicine physician, discusses the use of GLP agonists and bariatric surgery in treating obesity. She explains the different types of GLP agonists and their approved uses for obesity and weight loss. Dr. Berger also discusses the efficacy and side effects of these medications, as well as the importance of protein in the diet for weight loss. She emphasizes the need for patients to receive proper nutrition and exercise guidance, and highlights the role of vitamins and supplements in supporting weight loss. In this conversation, Dr. Reed Berger discusses the use of GLP agonists in weight loss and the management of obesity. He explains that GLP agonists can be used after bariatric surgery to help patients maintain weight loss. The timing of starting GLP agonists after surgery depends on the individual patient. Dr. Berger also discusses the phenomenon of 'Ozempic face' and the potential causes behind it. He mentions that weight loss medications like phentermine and combination medications like Contrave can still be used in conjunction with GLP agonists. He also highlights the challenges of prior authorizations and medication shortages in the field of obesity medicine.

Takeaways

• GLP agonists, such as Ozempic and Wegovy, are approved for weight loss and can help patients feel full and think about food less.